youtube_live
Q2 2027 earnings • in 3 days
See detailschevron_right
DOCS:NYSE
Doximity Inc
$32.87
arrow_upward
+0.34%(+0.11) 1D
$32.87
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 2, 4:00:02 PM GMT-5 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DOCS...
Open
$32.89
High
$33.74
Low
$32.80
Mkt. cap
5.86B
Avg. vol.
2.93M
Volume
1.77M
P/E ratio
38.98
52-wk high
$67.10
52-wk low
$17.15
EPS
$0.84
Beta
1.22
Shares outstanding
127.35M
No. of employees
880
Open
$32.89
High
$33.74
Low
$32.80
Mkt. cap
5.86B
Avg. vol.
2.93M
Volume
1.77M
P/E ratio
38.98
52-wk high
$67.10
52-wk low
$17.15
EPS
$0.84
Beta
1.22
Shares outstanding
127.35M
No. of employees
880
News stories
From web sources and news partners
investingLive
·
50 minutes ago
Nasdaq’s worst month since March 2025 puts returns on AI spending in focus, says BlackRock
KuCoin
·
7 minutes ago
Nasdaq-100 Enters Third Correction This Year Amid AI Concerns
Yahoo Finance
·
6 hours ago
Update: Dow Rises in Choppy Session Amid US Election Anxiety
Investor's Business Daily
·
2 hours ago
Dow Jones Futures: AI Trade Dives As Apple Tumbles On Earnings; Midterm Elections Next
Profile
Doximity is an online networking service for medical professionals. Launched in 2010, the platform offers its members curated medical news, telehealth tools, and case collaboration. Wikipedia
About Doximity Inc
CEOJeff Tangney
Employees880
FoundedJun 2010
HeadquartersSan Francisco, California, United States
SectorHealth care
Websitedoximity.com
Analyst ratings
Based on 16 analysts giving stock ratings to DOCS in the past 3 months
Buy
Buy
7
Hold
7
Sell
2
12-month forecast
Based on 16 Wall Street analysts offering 12 month price targets for DOCS in the last 3 months.
Highest
Current $32.87
$47.00 (+42.99%)
Average
$31.20 (-5.08%)
Lowest
$18.00 (-45.24%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Craig Hettenbach Morgan Stanley | Buy | Maintained | $35.00 | +6.5% | 10/21/2026 |
Stan Berenshteyn Wells Fargo | Sell | Maintained | $18.00 | -45.2% | 10/20/2026 |
Allen Lutz Bank of America Securities | Sell | Reiterated | $23.00 | -30% | 10/20/2026 |
Ryan Halsted RBC Capital | Buy | Maintained | $28.00 | -14.8% | 10/06/2026 |
Elizabeth Anderson CFA Evercore ISI | Hold | Maintained | $35.00 | +6.5% | 09/29/2026 |
Eugene Mannheimer Freedom Capital Markets | Hold | Downgraded | $27.00 | -17.9% | 09/08/2026 |
Glen Santangelo Barclays | Hold | Maintained | $27.00 | -17.9% | 08/20/2026 |
Jailendra Singh Truist Financial | Hold | Maintained | $24.00 | -27% | 08/13/2026 |
Steven Valiquette Mizuho Securities | Hold | Maintained | $28.00 | -14.8% | 08/11/2026 |
Alexei Gogolev J.P. Morgan | Hold | Maintained | $31.00 | -5.7% | 08/10/2026 |
Brian Peterson Raymond James | Buy | Maintained | $38.00 | +15.6% | 08/07/2026 |
Jessica Tassan Piper Sandler | Buy | Reiterated | $47.00 | +43% | 08/07/2026 |
Sean Dodge BMO Capital | Hold | Reiterated | $30.00 | -8.7% | 08/06/2026 |
Richard Close Canaccord Genuity | Buy | Reiterated | $36.00 | +9.5% | 08/07/2026 |
Scott Berg Needham | Buy | Maintained | $41.00 | +24.7% | 08/07/2026 |
Ryan MacDonald Needham | Buy | Maintained | $41.00 | +24.7% | 08/07/2026 |
Ryan Daniels William Blair | Buy | Maintained | - | - | 08/06/2026 |
Anne Samuel J.P. Morgan | Hold | Maintained | $28.00 | -14.8% | 05/14/2026 |
David Roman Goldman Sachs | Hold | Reiterated | $24.00 | -27% | 05/15/2026 |
Michael Cherny Leerink Partners | Buy | Reiterated | $25.00 | -23.9% | 05/15/2026 |
David Larsen BTIG | Hold | Downgraded | - | - | 05/14/2026 |
Vikram Kesavabhotla Robert W. Baird | Hold | Downgraded | $18.00 | -45.2% | 05/14/2026 |
Brian Tanquilut Jefferies | Hold | Downgraded | $19.00 | -42.2% | 05/14/2026 |
Scott Schoenhaus KeyBanc | Hold | Maintained | - | - | 05/14/2026 |
Next call in 3 days
Thu, Nov 5, 5:00 PM
Fiscal period
Q2 2027
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
- / $0.35
Revenue / Est. (USD)
- / 170.30M
Fiscal Q2 2027 earnings call
youtube_liveWaiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 168.52M | 185.05M | 145.37M | 156.62M |
Cost of goods sold | 16.42M | 18.70M | 19.41M | 23.69M |
Cost of revenue | 16.42M | 18.70M | 19.41M | 23.69M |
Research and development expenses | 30.20M | 34.60M | 39.11M | 38.48M |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 56.94M | 59.78M | 55.48M | 60.72M |
Operating expense | 87.14M | 94.38M | 94.59M | 99.19M |
Total operating expenses | 103.56M | 113.08M | 114.00M | 122.88M |
Operating income | 64.96M | 71.98M | 31.37M | 33.73M |
Other non operating income | -178.00K | -158.00K | -235.00K | -286.00K |
EBT including unusual items | 72.94M | 80.80M | 32.12M | 40.36M |
EBT excluding unusual items | 74.22M | 80.76M | 38.60M | 40.39M |
Income tax expense | 10.88M | 19.24M | 13.01M | 16.05M |
Effective tax rate | 14.92% | 23.81% | 40.49% | 39.76% |
Other operating expenses | - | - | - | - |
Net income | 62.06M | 61.56M | 19.11M | 24.32M |
Net profit margin | 36.82% | 33.27% | 13.15% | 15.53% |
Earnings per share | 0.45 | 0.46 | 0.26 | 0.29 |
Interest and investment income | 9.44M | 8.94M | 7.46M | 6.94M |
Interest expense | - | - | - | - |
Net interest expenses | 9.44M | 8.94M | 7.46M | 6.94M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 66.73M | 74.06M | 33.40M | 35.82M |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1
Upcoming events